Actinium Pharmaceuticals Inc (ATNM) Stock Price, Quote, News & History

ATNMAMEX
$0.9005
-0.0295-3.17%
Last update: Jul 13, 2:35 PM
Loading...

Key Statistics

Open
$0.92
Close
-
Volume / Avg.
74.57K / 174.62K
Day Range
$0.90 - $0.97
52 Wk Range
0.92 - 1.89
Market Cap
$28.25M
P/E Ratio
-
Dividend Yield
-
Exchange
AMEX
RSI
36
Short Interest
3%
Days to Cover
6.72

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-22.88M
Investing Cash Flow (TTM)
-106.00K
Financing Cash Flow (TTM)
-218.00K
Free Cash Flow (TTM)
-22.98M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
-23.20M

Analyst Trends and Forecast

1
Mar
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
-$11.43M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
322.47
PB Ratio (TTM)
12.66
Earnings Yield % (TTM)
-81.72%
Earnings Yield % (FWD)
-101.08%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.07

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-$11.00K
Total Cash
$42.13M
Debt to Equity
0.66
Issuance of Debt (TTM)
-$11.00K
Repayment of Debt (TTM)
-$11.00K

Key Statistics

Open
$0.92
Close
-
Volume / Avg.
74.57K / 174.62K
Day Range
$0.90 - $0.97
52 Wk Range
0.92 - 1.89
Market Cap
$28.25M
P/E Ratio
-
Dividend Yield
-
Exchange
AMEX
RSI
36
Short Interest
3%
Days to Cover
6.72

About

Sector
Health Care
Industry
Biotechnology
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of targeted radiotherapies using its Antibody Radiation Conjugates (ARCs) platform, which combines monoclonal antibodies with radioisotopes to selectively target a...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Actinium Pharmaceuticals (ATNM) stock?

A

You can purchase shares of Actinium Pharmaceuticals (AMEX:ATNM) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Actinium Pharmaceuticals (ATNM) competitors?

A

There are no as such competitors for Actinium Pharmaceuticals.

Q

What is the forecast, or price target, for Actinium Pharmaceuticals (ATNM) stock?

A

Actinium Pharmaceuticals has a consensus price target of $10.43.

Q

What is the current price for Actinium Pharmaceuticals (ATNM)?

A

The stock price for Actinium Pharmaceuticals (AMEX: ATNM) is $0.9005 last updated July 13, 2026 at 2:35 PM EDT.

Q

Does Actinium Pharmaceuticals (ATNM) pay a dividend?

A

There are no upcoming dividends for Actinium Pharmaceuticals.

Q

When is Actinium Pharmaceuticals (AMEX:ATNM) reporting earnings?

A

Actinium Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is Actinium Pharmaceuticals (ATNM) going to split?

A

There is no upcoming split for Actinium Pharmaceuticals.

Q

What sector and industry does Actinium Pharmaceuticals (ATNM) operate in?

A

Actinium Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.